Evidence map›Paper›PMID 41326600›Full record

ArticleScientific reports2025

An association of Mycoplasma pneumonia with lung function and laboratory parameters.

Ping Liu, Anni Cao, Xinyi Jia, Qiangquan Rong, Feng Liu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Glycyrrhizin alleviatesJournal of thoracic disease · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ping LiuDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China.
Anni CaoDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China.
Xinyi JiaDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China.
Qiangquan RongDepartment of Pediatrics, Nanjing Gaochun People's Hospital, Nanjing, 211300, China. ydrqq@sina.com.
Feng LiuDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China. axsliu@njmu.edu.cn.

Funding

Natural Science Foundation of Jiangsu Health Vocational College JKCY 202412
6 · The paper itself

Abstract

Mycoplasma pneumoniae (M. pneumoniae) is a significant pathogen causing community-acquired pneumonia in children aged 5 years and older. While numerous studies have demonstrated that M. pneumoniae infection can impair lung function, the dynamic changes in lung function following M. pneumoniae infection remain poorly understood. This study aimed to observe the dynamic changes in lung function after M. pneumoniae infection in children. Children with M. pneumoniae infection and healthy volunteers were recruited from Nanjing Gaochun People’s Hospital between February 2022 and January 2023. The M. pneumoniae-infected children were followed up for one year, with lung function assessed at admission, discharge, and at the 4th, 8th, and 12th months post-discharge. M. pneumoniae infection was found to be associated with lung function, which gradually recovered over time. Several factors were found to be associated with lung function, including lymphocyte count, albumin, prealbumin, carbon dioxide levels, A/G ratio, triglycerides, and apolipoprotein B. M. pneumoniae infection is indeed associated with pulmonary function in children.

Indexed as

LungMycoplasma pneumoniaePneumonia, MycoplasmaChildChild, PreschoolCommunity-Acquired PneumoniaFemaleHumansMaleRespiratory Function TestsChildrenDynamicsLung functionMycoplasma pneumonia

Identifiers

PMID41326600
PMCPMC12780173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.